INTERNATIONAL PATENT: TENEOTWO, INC. FILES APPLICATION FOR "THERAPEUTIC COMBINATIONS OF ACALABRUTINIB AND A MULTISPECIFIC ANTIBODY TO TREAT B-CELL MALIGNANCIES"

GENEVA, Oct. 28 -- TENEOTWO, INC. (1800 Concord PikeWilmington, DE 19803) filed a patent application (PCT/US2025/025337) for "THERAPEUTIC COMBINATIONS OF ACALABRUTINIB AND A MULTISPECIFIC ANTIBODY TO TREAT B-CELL MALIGNANCIES" on Apr 18, 2025. With publication no. WO/2025/222102, the details related to the patent application was published on Oct 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CAYATTE, Corinne (c/o MedImmune, LLCOne MedImmune WayGaithersburg, Maryland 20878), CIUCCI, Thomas (c/o AstraZeneca Pharmaceuticals LP1800 Concord Pike, P.O. Box 15437Wilmington, Delaware 19850-5437...